Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study

Journal of the National Cancer Institute

Volumn 89, Issue 12, 1997, Pages 881-886

  Fontanini, Gabriella ^a,c   Lucchi, Marco ^a   Vignati, Silvana ^a   Mussi, Alfredo ^a   Ciardiello, Fortunato ^b   De Laurentiis, Michelino ^b   De Placido, Sabino ^b   Basolo, Fulvio ^a   Angeletti, Carlo Alberto ^a   Bevilacqua, Generoso ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Division of Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR VASCULARIZATION;

EID: 0030996171     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.12.881     Document Type: Article

References (34)

1. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(4 Suppl): 225s-233s.
2. Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323: 561-5.
3. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 correlates with a poor prognosis in human lung cancer. Cancer Res 1992;52:4828-31.
4. Harpole DH Jr, Herndon JE 2nd, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995;55:51-6.
5. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D. et al. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral node-negative non-small cell lung cancer. Cancer 1992;70: 1520-7.
6. Scagliotti GV, Micela M, Gubetta L, Leonardo E, Cappia S, Borasio P, et al. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 1993;29A: 363-5.
7. Macchiarini P, Fontanini G, Hardin JM, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
8. Yamazaki K, Abe S, Takakawa H, Sukoh N, Watanabe N, Ogura S, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994;74:2245-50.
9. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, et al. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 1995;177:57-63.
10. Angeletti CA. Lucchi M, Fontanini G, Mussi A, Chella A, Ribechini A, et al. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence. Cancer 1996;78:409-15.
11. Harpole DH Jr, Richards WG, Herndon JE 2nd, Sugarbaker DJ. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 1996;61:1470-6.
12. Folkman J. What is the evidence that tumors are angiogenesis dependent? [editorial] J Natl Cancer Inst 1990;82:4-6.
13. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61.
14. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988; 133:419-23.
15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
16. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340: 1120-4.
17. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
18. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36: 193-204.
19. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993;55:739-44.
20. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
21. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33-41.
22. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996;56: 2671-6.
23. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC, et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 1996;179: 80-8.
24. Macchiarini P, Fontanini G, Dulmet E, de Montpreville V, Chapelier AR, Cerrina J, et al. Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading thoracic inlet. Ann Thorac Surg 1994;57: 1534-9.
25. World Health Organization. The World Health Organization. Histological typing of lung tumours. Am J Clin Pathol 1982;77:123-36.
26. American Joint Committee on Cancer. Manual for a staging of cancer. 4th ed. 1992;115-22.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
29. Cox DR. Regression model and life tables. J R Stat Soc 34 [series B]; 1972:187-220.
30. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
31. Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Important advances in oncology 1996. Philadelphia: Lippincott-Raven, 1996:167-90.
32. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993;29A: 1141-5.
33. Anthony PP, Ramani P. Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1. J Clin Pathol 1991;44:29-32.
34. Ingber D, Fujita M, Kishimoto S, Sudo K, Kanamaru T, Brem H, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348: 555-7.